Prostaglandin-associated periorbitopathy in latanoprost users

Prostaglandin-associated periorbitopathy in latanoprost users

Shunsuke Nakakura,1 Minamai Yamamoto,1 Etsuko Terao,1 Nozomi Nagatomi,1 Naoko Matsuo,1 Yausko Fujisawa,1 Yuki Fujio,1 Hitoshi Tabuchi,1 Yoshiaki Kiuchi2 1Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan; 2Department of Ophthalmology and Visual Sciences, Graduate School of Bio...

Full description

Bibliographic Details
Main Authors:	Nakakura S, Yamamoto M, Terao E, Nagatomi N, Matsuo N, Fujisawa Y, Fujio Y, Tabuchi H, Kiuchi Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-12-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/prostaglandin-associated-periorbitopathy-innbsplatanoprost-users-peer-reviewed-article-OPTH

Similar Items

Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment
by: Jose Manuel Abalo-Lojo, et al.
Published: (2023-02-01)

Prostaglandin-Associated Periorbitopathy: Report of three Cases and Review of Fundamental Physiopathology
by: Murat Küçükevcilioğlu, et al.
Published: (2013-01-01)

Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost
by: Maruyama Y, et al.
Published: (2015-08-01)

Cross-sectional study of the association between a deepening of the upper eyelid sulcus-like appearance and wide-open eyes.
by: Shunsuke Nakakura, et al.
Published: (2014-01-01)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
by: Shimizu Y, et al.
Published: (2015-03-01)

15. NONINVASIVE LOCALIZED ADIPOSE REDUCTION WITH THE PROSTAGLANDIN ANALOG LATANOPROST
by: David T. Guerrero, MS, et al.
Published: (2022-04-01)

The whole macular choroidal thickness in subjects with primary open angle glaucoma.
by: Shunsuke Nakakura, et al.
Published: (2014-01-01)

Iris Morphological Features in Patients with 360° Angle-Closure Neovascular Glaucoma: An Anterior Segment Optical Coherence Tomography Study
by: Yui Kobayashi, et al.
Published: (2018-10-01)

CHARGE Syndrome Associated with Angle Closure despite High Myopia: A Case Report with Structural Suggestion
by: Saki Dote, et al.
Published: (2020-01-01)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
by: Yin J, et al.
Published: (2019-01-01)

Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
by: Asaoka D, et al.
Published: (2015-03-01)

Latanoprost could exacerbate the progression of presbyopia.
by: Masahiko Ayaki, et al.
Published: (2019-01-01)

Effect of latanoprost on open angle glaucoma
by: Min Zhang, et al.
Published: (2018-06-01)

Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids /
by: Fumiyuki Kiuchi

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold
by: Zhang Y, et al.
Published: (2015-10-01)

Topical latanoprost causes posterior movement of lens in a patient with exfoliation syndrome and subluxated lens: a case report
by: Kanamoto Takashi, et al.
Published: (2007-12-01)

Latanoprost-associated cystoid macular edema in a patient with phakic eyes
by: Wei-Che Lin, et al.
Published: (2023-01-01)

Colocalization of prostaglandin F2α receptor FP and prostaglandin F synthase-I in the spinal cord
by: T. Suzuki-Yamamoto, et al.
Published: (2009-10-01)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
by: Yang X, et al.
Published: (2015-03-01)

A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature
by: Nakamura Y, et al.
Published: (2015-09-01)

Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
by: Nagahara Y, et al.
Published: (2015-06-01)

“Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost”
by: David Chung, et al.
Published: (2022-06-01)

Severe cutaneous reaction to latanoprost eye drops
by: Ivan Yeu Ming Yip, et al.
Published: (2018-01-01)

Tear biomarkers in latanoprost and bimatoprost treated eyes.
by: Shweta Reddy, et al.
Published: (2018-01-01)

Upconversion nanoparticles conjugated with curcumin as a photosensitizer to inhibit methicillin-resistant Staphylococcus aureus in lung under near infrared light
by: Ye Y, et al.
Published: (2014-11-01)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
by: Inoue K, et al.
Published: (2012-05-01)

Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot
by: Shi XL, et al.
Published: (2014-11-01)

The Efficacy of Latanoprost in the Treatment of Alopecia Areata of Eyelashes and Eyebrows
by: Gita Faghihi, et al.
Published: (2012-03-01)

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
by: Qu M, et al.
Published: (2015-06-01)

MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus
by: Yang X, et al.
Published: (2022-02-01)

Perbandingan penurunan tekanan intra okuler antara latanoprost 0,005 persen dengan kombinasi latanoprost 0,005 persen - pilokarpin 2 persen
by: , GANI, Tatang Talka, et al.
Published: (2004)

The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes
by: Bacci MR, et al.
Published: (2015-06-01)

Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost
by: Elena Nutterova, et al.
Published: (2022-07-01)

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
by: Thomas Ravi, et al.
Published: (2003-01-01)

Nanomedicine for glaucoma : liposomes provide sustained release of latanoprost in the eye
by: Natarajan, Jayaganesh V., et al.
Published: (2014)

Topical latanoprost solution in combination with microneedling in treatment of segmental vitiligo
by: Khaled Mohamed Tawfik, et al.
Published: (2020-01-01)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
by: Beck DER, et al.
Published: (2017-08-01)

Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
by: Natarajan JV, et al.
Published: (2012-01-01)

Peripheral Latanoprost Administration Lowers Intraocular Pressure in the Wistar Rat
by: Maciej Świątkiewicz, et al.
Published: (2020-08-01)

Comparative analysis of phytolith spectra&nbsp;of steppe and forest phytocoenoses&nbsp;
by: Natalia Y. Speranskaya, et al.
Published: (2021-12-01)